Author

Maud Marques

Observed names: M. Marques, Marques, Maud

Observed institutions: Centre National de la Recherche Scientifique, Université de Sherbrooke, Jewish General Hospital, Laboratoire de Biologie Moléculaire des Eucaryotes, Lady Davis Institute for Medical Research, McGill University, Concordia University

ORCID: 0009-0007-2032-7923

Observed ORCIDs: 0009-0007-2032-7923, 0000-0001-6313-9403

OpenAlex ID: A5012037815

Epigenetic silencing of tumor suppressor genes: Paradigms, puzzles, and potential

2016 · Anna Kazanets, Tatiana Shorstova, et al. · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · 199

PDF

Inhibition of PI3K-AKT-mTOR pathway sensitizes endometrial cancer cell lines to PARP inhibitors

2017 · Charles-André Philip, Ido Laskov, et al. · BMC Cancer · 115

PDF

Reconciling the positive and negative roles of histone H2A.Z in gene transcription

2010 · Maud Marques, Liette Laflamme, et al. · Epigenetics · 109

PDF

Anticancer Properties ofPhyllanthus emblica(Indian Gooseberry)

2015 · Tiejun Zhao, Qiang Sun, et al. · Oxidative Medicine and Cellular Longevity · 107

PDF

Estrogen receptor α can selectively repress dioxin receptor-mediated gene expression by targeting DNA methylation

2013 · Maud Marques, Liette Laflamme, et al. · Nucleic Acids Research · 80

PDF

CTCF facilitates DNA double-strand break repair by enhancing homologous recombination repair

2017 · Khalid Hilmi, Maïka Jangal, et al. · Science Advances · 79

Competition between translation initiation factor eIF5 and its mimic protein 5MP determines non-AUG initiation rate genome-wide

2017 · Leiming Tang, Jacob Morris, et al. · Nucleic Acids Research · 73

PDF

Genome-wide targeting of the epigenetic regulatory protein CTCF to gene promoters by the transcription factor TFII-I

2015 · Rodrigo Peña-Hernández, Maud Marques, et al. · Proceedings of the National Academy of Sciences · 67

PDF

SWI/SNF-Compromised Cancers Are Susceptible to Bromodomain Inhibitors

2019 · Tatiana Shorstova, Maud Marques, et al. · Cancer Research · 65

Haploinsufficiency of the ESCRT Component HD-PTP Predisposes to Cancer

2016 · Sanaz Manteghi, Marie-Claude Gingras, et al. · Cell Reports · 53

PDF

Low levels of 3,3′-diindolylmethane activate estrogen receptor α and induce proliferation of breast cancer cells in the absence of estradiol

2014 · Maud Marques, Liette Laflamme, et al. · BMC Cancer · 43

PDF

Oncogenic activity of poly (ADP-ribose) glycohydrolase

2018 · Maud Marques, Maika Jangal, et al. · Oncogene · 41

PDF

MNK1/NODAL Signaling Promotes Invasive Progression of Breast Ductal Carcinoma In Situ

2019 · Qianyu Guo, Vivian Z. Li, et al. · Cancer Research · 35

Gallotannin Imposes S Phase Arrest in Breast Cancer Cells and Suppresses the Growth of Triple-Negative Tumors In Vivo

2014 · Tiejun Zhao, Qiang Sun, et al. · PLoS ONE · 32

PDF

Insights into a novel nuclear function for Fascin in the regulation of the amino-acid transporter SLC3A2

2016 · Amine Saad, Krikor Bijian, et al. · Scientific Reports · 29

PDF

Bsr, a Nuclear-retained RNA with Monoallelic Expression

2007 · Hélène Royo, Eugenia Basyuk, et al. · Molecular Biology of the Cell · 28

PCRTiler: automated design of tiled and specific PCR primer pairs

2010 · Alain L. Gervais, Maud Marques, et al. · Nucleic Acids Research · 27

PDF

Proteogenomics of Colorectal Cancer Liver Metastases: Complementing Precision Oncology with Phenotypic Data

2019 · Bernhard Blank-Landeshammer, Vincent R. Richard, et al. · Cancers · 25

PDF

Analysis of the Genomic Landscape in ALK+ NSCLC Patients Identifies Novel Aberrations Associated with Clinical Outcomes

2019 · Mathilde Couëtoux du Tertre, Maud Marques, et al. · Molecular Cancer Therapeutics · 25

Chemotherapy reduces PARP1 in cancers of the ovary: implications for future clinical trials involving PARP inhibitors

2015 · Maud Marques, Marie-Claude Beauchamp, et al. · BMC Medicine · 19

PDF

Defining Molecular Sensors to Assess Long-Term Effects of Pesticides on Carcinogenesis

2014 · Fanny L'Héritier, Maud Marques, et al. · International Journal of Molecular Sciences · 16

PDF

Copy number and transcriptome alterations associated with metastatic lesion response to treatment in colorectal cancer

2021 · Karen Gambaro, Maud Marques, et al. · Clinical and Translational Medicine · 11

PDF

Third-line treatment patterns in HER2-positive metastatic breast cancer: a retrospective analysis of real-world data in Canada

2023 · Karen Gambaro, Mélanie Groleau, et al. · Journal of Pharmacy & Pharmaceutical Sciences · 10

PDF

Analysis of changes to mRNA levels and CTCF occupancy upon TFII-I knockdown

2014 · Maud Marques, Rodrigo Peña Hernández, et al. · Genomics Data · 4

PDF

Real-World Safety of Niraparib for Maintenance Treatment of Ovarian Cancer in Canada

2024 · Qi Guan, Suriya J. Aktar, et al. · Current Oncology · 3

Works count: 91

Citation count: 1,307

H-index: 19

I10-index: 23